Immunological tests in carcinoma of the prostate.
作者信息
Evans C M, Bowen J G
出版信息
Proc R Soc Med. 1977 Jun;70(6):417-20. doi: 10.1177/003591577707000614.
Abstract
摘要
相似文献
1
Immunological tests in carcinoma of the prostate.前列腺癌的免疫学检测
Proc R Soc Med. 1977 Jun;70(6):417-20. doi: 10.1177/003591577707000614.
2
3
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.前列腺癌中的白细胞黏附抑制与免疫反应性。II. 抗肿瘤细胞介导免疫的组织和疾病特异性
Eur J Cancer (1965). 1979 Jan;15(1):133-6. doi: 10.1016/0014-2964(79)90215-9.
4
Prostaglandin E2 affects the tumor immune response in prostatic carcinoma.
J Urol. 1981 Jul;126(1):65-70. doi: 10.1016/s0022-5347(17)54384-0.
5
Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.循环免疫复合物对前列腺癌致敏白细胞体外反应性的抑制作用
Experientia. 1987 Aug 15;43(8):916-7. doi: 10.1007/BF01951666.
6
7
Hormonal therapy and alterations of immunity in prostatic cancer.
Neoplasma. 1981;28(3):345-50.
8
9
Cell-mediated immunity in prostatic cancer.前列腺癌中的细胞介导免疫。
Clin Oncol. 1980 Sep;6(3):253-64.
10
Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.二硝基氯苯（DNCB）皮肤超敏反应与DNCB包被的人红细胞对白细胞迁移的抑制作用之间的相关性。
Arch Immunol Ther Exp (Warsz). 1981;29(1):29-33.
引用本文的文献
1
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database?在 SARS-CoV-2 潘多拉大流行中：通过粪便 Adnab-9 与 p87：血转铁蛋白的结合来衡量的预存肠道先天免疫系统的状态，能否预测前瞻性人群数据库中 COVID-19 的易感性和存活率？
Int J Mol Sci. 2023 Apr 19;24(8):7536. doi: 10.3390/ijms24087536.
2
Serial immune function testing to predict clinical disease relapse in patients with solid tumors.通过系列免疫功能检测预测实体瘤患者的临床疾病复发
Cancer Immunol Immunother. 1983;15(3):165-71. doi: 10.1007/BF00199159.
本文引用的文献
1
IMMUNOLOGICAL DEFECT IN AGED POPULATION AND ITS RELATIONSHIP TO CANCER.老年人群的免疫缺陷及其与癌症的关系。
Cancer. 1965 Feb;18:201-4. doi: 10.1002/1097-0142(196502)18:2<201::aid-cncr2820180211>3.0.co;2-v.
2
Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.对人肿瘤细胞膜提取物的迟发型皮肤过敏反应。
Clin Exp Immunol. 1971 Jul;9(1):45-56.
3
Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.通过白细胞粘附抑制试验检测癌症患者的抗肿瘤细胞介导免疫和血清阻断因子。
Br J Cancer. 1974 Jan;29(1):31-5. doi: 10.1038/bjc.1974.4.
4
Sensitization to tumour-associated antigens in human breast carcinoma.人类乳腺癌中对肿瘤相关抗原的致敏作用。
Int J Cancer. 1974 Jul 15;14(1):19-25. doi: 10.1002/ijc.2910140103.
5
Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure.
Cancer. 1974 Apr;33(4):952-8. doi: 10.1002/1097-0142(197404)33:4<952::aid-cncr2820330409>3.0.co;2-q.
6
Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.急性白血病中对肿瘤相关抗原及其他抗原的皮肤迟发型超敏反应
Int J Cancer. 1973 Sep 15;12(2):409-19. doi: 10.1002/ijc.2910120212.
7
Effect of murine milk samples and human breast tissues on human leukocyte migration indices.鼠乳样本和人乳腺组织对人白细胞迁移指数的影响。
Cancer Res. 1974 May;34(5):1054-60.
8
Immunological aspects of chemical carcinogenesis.化学致癌作用的免疫学方面
Adv Cancer Res. 1973;18:1-75. doi: 10.1016/s0065-230x(08)60750-2.
9
Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors.
Natl Cancer Inst Monogr. 1972 Dec;35:117-24.
10
Immunologic impairment in patients with non-lymphoid cancer: correlation with the tumoral stage, response to treatment and survival.非淋巴细胞癌患者的免疫功能损害：与肿瘤分期、治疗反应及生存的相关性
Cancer. 1976 Feb;37(2):724-8. doi: 10.1002/1097-0142(197602)37:2<724::aid-cncr2820370219>3.0.co;2-g.
Zotero 插件